Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H17BrN2O6S |
InChIKeyQXDSUYVYKQGWBY-UHFFFAOYSA-N |
CAS Registry1395472-39-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 01 Mar 2021 |